The FDA has proposed to withdraw its approval of avacopan for ANCA-associated vasculitis, alleging that employees of the ...
Q1 2026 Earnings Call May 13, 2026 4:30 PM EDTCompany ParticipantsPeter Mariani - Chief Financial OfficerPhillip Chan - ...
Regenxbio announces positive results from pivotal phase III AFFINITY DUCHENNE study of RGX-202 to treat Duchenne muscular dystrophy: Rockville, Maryland Friday, May 15, 2026, 14:0 ...
REGENXBIO Inc. announced positive topline and interim functional data from the pivotal Phase III portion of the Phase I/II/III AFFINITY DUCHENNE® trial of RGX-202, a potential best-in-class gene ...
Background Hearing loss (HL) imposes a substantial burden on families and society and is the largest modifiable risk factor ...
Objectives We investigated associations between maternal occupations and a diagnosis of autism spectrum disorder (ASD) in offspring. Methods We obtained data for 1702 ASD cases born between 1973 and ...
For decades, pharmacy automation has been defined by what it can do mechanically — count, sort, dispense. Robots fill bins. Barcode systems flag errors. Cabinets track controlled substances. These are ...
AI-enabled research tools can accelerate health research, but their data-science roots may clash with epidemiological ...
With its link to more than $1 trillion in welfare losses globally in 2023, tuberculosis is described as “a macroeconomic ...
Objectives To evaluate the performance of large language models (LLMs) in risk of bias assessment and to examine whether ...
BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results